{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:50:52Z","timestamp":1785174652826,"version":"3.55.0"},"reference-count":58,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant melanoma frequently develops cutaneous and\/or subcutaneous metastases during the course of the disease. These may present as non-nodal locoregional metastases (microsatellite, satellite, or in-transit) included in stage III or as distant metastases in stage IV. Their presentation is heterogeneous and associated with significant morbidity resulting from both disease-related functional damage and treatment side effects. The standard treatment is surgical excision, whereas local therapies or systemic therapies have a role when surgery is not indicated. Radiotherapy can be used in the local management of ITM, subcutaneous relapses, or distant metastases to provide symptom relief and prolong regional disease control. To increase the local response without increasing toxicity, the addition of hyperthermia and intralesional therapies to radiotherapy appear to be very promising. Boron neutron capture therapy, based on nuclear neutron capture and boron isotope fission reaction, could be an alternative to standard treatments, but its use in clinical practice is still limited. The potential benefit of combining radiotherapy with targeted therapies and immunotherapy has yet to be explored in this lesion setting. This review explores the role of radiotherapy in the treatment of cutaneous and subcutaneous lesions, its impact on outcomes, and its association with other treatment modalities.<\/jats:p>","DOI":"10.3390\/cancers13225859","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T02:55:17Z","timestamp":1637636117000},"page":"5859","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Radiotherapy in the Treatment of Subcutaneous Melanoma"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-1735","authenticated-orcid":false,"given":"Valentina","family":"Borzillo","sequence":"first","affiliation":[{"name":"Radiation Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Muto","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/CMR.0b013e32832ac775","article-title":"Skin metastases of malignant melanoma: A clinical and prognostic survey","volume":"19","author":"Savoia","year":"2009","journal-title":"Melanoma Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1245\/s10434-014-4100-0","article-title":"In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy","volume":"22","author":"Read","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_4","first-page":"647","article-title":"Management of in-transit melanoma metastases: A review","volume":"89","author":"Tie","year":"2018","journal-title":"ANZ J. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ajd.12293","article-title":"Prognosis associated with cutaneous melanoma metastases","volume":"56","author":"Pan","year":"2015","journal-title":"Australas. J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejso.2016.10.005","article-title":"Diagnosis and treatment of in-transit melanoma metastases","volume":"43","author":"Testori","year":"2017","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_7","first-page":"743","article-title":"Radiation Therapy in the Management of Malignant Melanoma","volume":"29","author":"Mahadevan","year":"2015","journal-title":"Oncology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jso.22029","article-title":"Local and intralesional therapy of in-transit melanoma metastases","volume":"104","author":"Testori","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jso.24580","article-title":"Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma","volume":"115","author":"Foote","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0360-3016(85)90223-8","article-title":"Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves","volume":"11","author":"Fertil","year":"1985","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_11","first-page":"4","article-title":"The radioresponsiveness of melanoma","volume":"8","author":"Doss","year":"1982","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_12","first-page":"830","article-title":"The radiation response of human malignant melanoma cells grown in vitro","volume":"31","author":"Barranco","year":"1971","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0167-8140(89)90017-0","article-title":"Clinical radiobiology of malignant melanoma","volume":"16","author":"Bentzen","year":"1989","journal-title":"Radiother. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0360-3016(86)90378-0","article-title":"The role of radiotherapy in recurrent and metastatic malignant melanoma: A clinical radiobiological study","volume":"12","author":"Overgaard","year":"1986","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0360-3016(85)90042-2","article-title":"A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma","volume":"11","author":"Overgaard","year":"1985","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0167-8140(86)80048-2","article-title":"Some factors of importance in the radiation treatment of malignant melanoma","volume":"5","author":"Overgaard","year":"1986","journal-title":"Radiother. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0360-3016(91)90053-7","article-title":"Fraction size in external beam radiation therapy in the treatment of melanoma","volume":"20","author":"Sause","year":"1991","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3109\/0284186X.2010.489570","article-title":"A review of in vitro experimental evidence for the effect of spatial and temporal modulation of radiation dose on response","volume":"49","author":"Suchowerska","year":"2010","journal-title":"Acta Oncol."},{"key":"ref_19","first-page":"51","article-title":"In vitro sensitivity of malignant melanoma cells lines to photon and heavy ion radiation","volume":"17","author":"Aninditha","year":"2019","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2016.12.003","article-title":"Melanoma: Last call for radiotherapy","volume":"110","author":"Espenel","year":"2016","journal-title":"Crit. Rev. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.critrevonc.2016.01.016","article-title":"Role of radiation therapy in melanomas: Systematic review and best practice in 2016","volume":"99","author":"Fort","year":"2016","journal-title":"Crit. Rev. Oncol."},{"key":"ref_22","unstructured":"Alexander, F.I., and Osman, F. Radiation Oncology in the Era of Big Data and Machine Learning for Precision Medicine, 2019, Arhtificial Intelligence-Applications in Medicine and Biology, Marco Antonio Aceves-Fernandez, IntechOpen. Available online: https:\/\/www.intechopen.com\/chapters\/66246."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1097\/CM9.0000000000001113","article-title":"Development and validation of radiomics model built by incorporating machine learning for identifying liver fibrosis and early-stage cirrhosis","volume":"133","author":"Qiu","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.canrad.2020.01.011","article-title":"Radiomics: A primer for the radiation oncologist","volume":"24","author":"Bibault","year":"2020","journal-title":"Cancer Radiother."},{"key":"ref_25","first-page":"15","article-title":"Role of radiotherapy and hyperthermia in the management of malignant melanoma","volume":"12","author":"Johnson","year":"1996","journal-title":"Semin. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0167-8140(86)80016-0","article-title":"Combined treatment with radiation and hyperthermia in metastatic malignant melanoma","volume":"6","author":"Blank","year":"1986","journal-title":"Radiother. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(95)90463-8","article-title":"Randomised trial of hy-perthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma","volume":"345","author":"Overgaard","year":"1995","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/1097-0142(19820801)50:3<478::AID-CNCR2820500316>3.0.CO;2-6","article-title":"Combination hyperthermia and radiation therapy for malignant melanoma","volume":"50","author":"Kim","year":"1982","journal-title":"Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1097-0142(19930701)72:1<287::AID-CNCR2820720150>3.0.CO;2-L","article-title":"Thermoradiation therapy for superficial malignant tumors","volume":"72","author":"Engin","year":"1993","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/02656738809016491","article-title":"Thermoradiotherapy of malignant melanoma","volume":"4","author":"Emami","year":"1988","journal-title":"Int. J. Hyperth."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000421-199104000-00008","article-title":"Randomized Phase III Study Comparing Irradiation and Hyperthermia with Irradiation Alone in Superficial Measurable Tumors","volume":"14","author":"Perez","year":"1991","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02656730150201552","article-title":"Hyperthermia in oncology","volume":"17","author":"Falk","year":"2001","journal-title":"Int. J. Hyperth."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdf280","article-title":"Heating the patient: A promising approach?","volume":"13","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_34","first-page":"139","article-title":"Thermoradiotherapy in the management of superficial malignant tumors","volume":"1","author":"Engin","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Paul, E., M\u00fcller, I., Renner, H., B\u00f6deker, R.-H., and Cochran, A.J. (2003). Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injection. Melanoma Res., 13.","DOI":"10.1097\/00008390-200312000-00011"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/1097-0142(19820915)50:6<1100::AID-CNCR2820500613>3.0.CO;2-6","article-title":"Combined BCG and irradiation treatment of skin metastases originating from malignant melanoma","volume":"50","author":"Plesnicar","year":"1982","journal-title":"Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.21147\/j.issn.1000-9604.2016.06.10","article-title":"Boron neutron capture therapy for malignant melanoma: First clinical case report in China","volume":"28","author":"Yong","year":"2016","journal-title":"Chin. J. Cancer Res."},{"key":"ref_38","first-page":"1","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.apradiso.2009.03.020","article-title":"BNCT for skin melanoma in extremities: Updated Argentine clinical results","volume":"67","author":"Roth","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jrr\/rraa068","article-title":"Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)","volume":"61","author":"Hiratsuka","year":"2020","journal-title":"J. Radiat. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brachy.2020.04.004","article-title":"The American Brachytherapy society consensus statement for skin brachytherapy","volume":"19","author":"Shah","year":"2020","journal-title":"Brachytherapy"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jso.2930430407","article-title":"Role of brachytherapy in malignant melanoma: A preliminary report","volume":"43","author":"Chadha","year":"1990","journal-title":"J. Surg. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0151-9638(06)70867-5","article-title":"Traitement par curieth\u00e9rapie interstitielle du m\u00e9lanome primitif cutan\u00e9: 4 cas","volume":"133","author":"Mortier","year":"2006","journal-title":"Ann. Dermatol Venereol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1754-9485.2011.02253.x","article-title":"Treatment of regional cutaneous nodular metastases from melanoma using high-dose rate mould brachytherapy","volume":"55","author":"Chaudhuri","year":"2011","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"key":"ref_46","first-page":"259","article-title":"Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers","volume":"24","author":"Formenti","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.023","article-title":"Radiation Therapy and the In Situ Vaccination Approach","volume":"108","author":"Golden","year":"2020","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation Therapy to Convert the Tumor Into an In Situ Vaccine","volume":"84","author":"Formenti","year":"2012","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semradonc.2014.07.004","article-title":"Combination of Radiotherapy and Immune Checkpoint Inhibitors","volume":"25","author":"Pilones","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.trecan.2016.05.002","article-title":"Radiotherapy: Changing the Game in Immunotherapy","volume":"2","author":"Demaria","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.soc.2017.01.007","article-title":"Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management","volume":"26","author":"Ahmed","year":"2017","journal-title":"Surg. Oncol. Clin. North. Am."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40425-016-0156-7","article-title":"Current clinical trials testing the combination of immunotherapy with radiotherapy","volume":"4","author":"Kang","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41419-019-2048-5","article-title":"Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma","volume":"10","author":"Fattore","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ijrobp.2016.01.038","article-title":"Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)","volume":"95","author":"Anker","year":"2016","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/annonc\/mdv139","article-title":"Radiosensitization by BRAF inhibitor therapy\u2014mechanism and frequency of toxicity in melanoma patients","volume":"26","author":"Hecht","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/fon.15.297","article-title":"Radiotherapy with BRAF inhibitor therapy for melanoma: Progress and possibilities","volume":"12","author":"Zahnreich","year":"2016","journal-title":"Futur. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/bjc.2017.489","article-title":"Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients","volume":"118","author":"Hecht","year":"2018","journal-title":"Br. J. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/22\/5859\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:34:05Z","timestamp":1760168045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/22\/5859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":58,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cancers13225859"],"URL":"https:\/\/doi.org\/10.3390\/cancers13225859","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}